Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

(-)-Tarchonanthuslactone: Design of New Analogues, Evaluation of their Antiproliferative Activity on Cancer Cell Lines, and Preliminary Mechanistic Studies

Full text
Author(s):
Toneto Novaes, Luiz Fernando [1] ; Avila, Carolina Martins [1] ; Pelizzaro-Rocha, Karin Juliane [2] ; Vendramini-Costa, Debora Barbosa [3] ; Dias, Marina Pereira [2] ; Barbosa Trivella, Daniela Barreto [4] ; de Carvalho, Joao Ernesto [3] ; Ferreira-Halder, Carmen Verissima [2] ; Pilli, Ronaldo Aloise [1]
Total Authors: 9
Affiliation:
[1] Univ Estadual Campinas, UNICAMP, Inst Chem, BR-13084971 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Inst Biol, Dept Biochem, BR-13083862 Campinas, SP - Brazil
[3] Univ Estadual Campinas, UNICAMP, Div Pharmacol & Toxicol CPQBA, BR-13083970 Campinas, SP - Brazil
[4] Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: CHEMMEDCHEM; v. 10, n. 10, p. 1687-1699, OCT 2015.
Web of Science Citations: 5
Abstract

Natural products containing the alpha,beta-unsaturated delta-lactone skeleton have been shown to possess a variety of biological activities. The natural product (-)-tarchonanthuslactone (1) possessing this privileged scaffold is a popular synthetic target, but its biological activity remains underexplored. Herein, the total syntheses of dihydropyran-2-ones modeled on the structure of 1 were undertaken. These compounds were obtained in overall yields of 17-21 % based on the Keck asymmetric allylation reaction and were evaluated in vitro against eight different cultured human tumor cell lines. We further conducted initial investigation into the mechanism of action of selected analogues. Dihydropyran-2-one 8 {[}(S,E)-(6-oxo-3,6-dihydro-2H-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate], a simplified analogue of (-)-tarchonanthuslactone (1) bearing an additional electrophilic site and a catechol system, was the most cytotoxic and selective compound against six of the eight cancer cell lines analyzed, including the pancreatic cancer cell line. Preliminary studies on the mechanism of action of compound 8 on pancreatic cancer demonstrated that apoptotic cell death takes place mediated by an increase in the level of reactive oxygen species. It appears as though compound 8, possessing two Michael acceptors and a catechol system, may be a promising scaffold for the selective killing of cancer cells, and thus, it deserves further investigation to determine its potential for cancer therapy. (AU)

FAPESP's process: 10/08673-6 - Studies toward the synthesis of analogues of fostriecin and total synthesis and structural elucidation of Coibacinas a and b
Grantee:Carolina Martins Avila de Sant'Ana
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 09/51602-5 - Chemical biology: new natural and synthetic molecular targets against cancer, structural studies, biological evaluation and mode of action
Grantee:Ronaldo Aloise Pilli
Support type: Research Projects - Thematic Grants
FAPESP's process: 12/09254-2 - Synthesis of the tarchonanthuslactone, analogues and evaluation of anticancer and antidiabetic activity
Grantee:Luiz Fernando Toneto Novaes
Support type: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 12/24385-6 - Influence of protein phosphatases inhibitors in the expression and / or activity of protein kinases in pancreatic cancer
Grantee:Marina Pereira Dias
Support type: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 13/08896-3 - Biochemical mapping of antitumor mechanism of calix[6]arene in human pancreatic cancer cell: investigation of intracellular trafficking, of kinome and microRNA expression
Grantee:Karin Juliane Pelizzaro Rocha
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 10/17544-5 - Structural and molecular bases of inhibitor recognition by the CDC-25 and LMW-PTP human protein phosphatases involved in cancer
Grantee:Daniela Barretto Barbosa Trivella
Support type: Scholarships in Brazil - Post-Doctorate